State-of-the-art polymeric nanoparticles as promising therapeutic tools against human bacterial infections

Abstract

Infectious diseases kill over 17 million people a year, among which bacterial infections stand out. From all the bacterial infections, tuberculosis, diarrhoea, meningitis, pneumonia, sexual transmission diseases and nosocomial infections are the most severe bacterial infections, which affect millions of people worldwide. Moreover, the indiscriminate use of antibiotic drugs in the last decades has triggered an increasing multiple resistance towards these drugs, which represent a serious global socioeconomic and public health risk. It is estimated that 33,000 and 35,000 people die yearly in Europe and the United States, respectively, as a direct result of antimicrobial resistance. For all these reasons, there is an emerging need to find novel alternatives to overcome these issues and reduced the morbidity and mortality associated to bacterial infectious diseases. In that sense, nanotechnological approaches, especially smart polymeric nanoparticles, has wrought a revolution in this field, providing an innovative therapeutic alternative able to improve the limitations encountered in available treatments and capable to be effective by theirselves. In this review, we examine the current status of most dangerous human infections, together with an in-depth discussion of the role of nanomedicine to overcome the current disadvantages, and specifically the most recent and innovative studies involving polymeric nanoparticles against most common bacterial infections of the human body.

Progress in the Application of Nanoparticles and Graphene as Drug Carriers and on the Diagnosis of Brain Infections

“…There has been an advancement in the polymeric role recently, and the concept of antimicrobial polymers has originated [ 43 ]. They mimic the chemical properties of the antimicrobial peptides that are native to the human body and defend against bacterial invasion [ 44 ].…”

Cancer Nanopharmaceuticals: Physicochemical Characterization and In Vitro/In Vivo Applications

“…Delivery takes place in specific parts of the body, without affecting healthy tissues mainly by the type of nanomaterial [ 86 ]. These nanomaterials are customized in such a way to increase their selectivity and accumulation in tumors by the EPR effect [ 113 , 174 ]. There are two distinct groups of nanomaterials, inorganic and organic.…”

Recent trends of NFκB decoy oligodeoxynucleotide-based nanotherapeutics in lung diseases

“…Polymeric nanoparticles have received much attention among other types of nanocarriers due to their biodegradability and superior biocompatibility [146]. Moreover, ODNs encapsulated within these nanoparticles could be considered as a powerful approach for enhancing the ODNs long-term release by protecting against in vivo degradation after administration [147].…”